<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08623592</doc-number>
<kind>B2</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>53</s160>
</s100>
<s200>
<s210>1</s210>
<s211>119</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 1
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1               5                   10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser His Tyr
            20                  25                  30
Val Met Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Ser Ile Ser Ser Ser Gly Gly Trp Thr Leu Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Thr Arg Gly Leu Lys Met Ala Thr Ile Phe Asp Tyr Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115
</s400>
<s200>
<s210>2</s210>
<s211>111</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 2
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1               5                   10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr
            20                  25                  30
Asn Val Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Ile Ile Tyr Glu Val Ser Gln Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser
                85                  90                  95
Ser Ile Phe Val Ile Phe Gly Gly Gly Thr Lys Val Thr Val Leu
            100                 105                 110
</s400>
<s200>
<s210>3</s210>
<s211>118</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 3
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1               5                   10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ala Tyr
            20                  25                  30
Asn Met Arg Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Val Ile Tyr Pro Ser Gly Gly Ala Thr Arg Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Gly Tyr Tyr Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly Thr
            100                 105                 110
Leu Val Thr Val Ser Ser
        115
</s400>
<s200>
<s210>4</s210>
<s211>110</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 4
Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
1               5                   10                  15
Arg Val Thr Ile Ser Cys Ser Gly Ser Asp Ser Asn Ile Gly Arg Asn
            20                  25                  30
Tyr Ile Tyr Trp Tyr Gln Gln Phe Pro Gly Thr Ala Pro Lys Leu Leu
        35                  40                  45
Ile Tyr Arg Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Ile Ser
    50                  55                  60
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg
65                  70                  75                  80
Ser Glu Asp Glu Ala Glu Tyr His Cys Gly Thr Trp Asp Asp Ser Leu
                85                  90                  95
Ser Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110
</s400>
<s200>
<s210>5</s210>
<s211>122</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 5
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1               5                   10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ala Tyr
            20                  25                  30
Gly Met Gly Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Tyr Ile Ser Pro Ser Gly Gly His Thr Lys Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Lys Val Leu Glu Thr Gly Leu Leu Val Asp Ala Phe Asp Ile Trp
            100                 105                 110
Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120
</s400>
<s200>
<s210>6</s210>
<s211>106</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 6
Gln Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Tyr Pro Gly Gln
1               5                   10                  15
Thr Ala Ser Ile Thr Cys Ser Gly Asp Gln Leu Gly Ser Lys Phe Val
            20                  25                  30
Ser Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Val Leu Val Met Tyr
        35                  40                  45
Lys Asp Lys Arg Arg Pro Ser Glu Ile Pro Glu Arg Phe Ser Gly Ser
    50                  55                  60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Ile
65                  70                  75                  80
Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Tyr Val
                85                  90                  95
Phe Gly Thr Gly Thr Lys Val Thr Val Leu
            100                 105
</s400>
<s200>
<s210>7</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 7
His Tyr Val Met Ala
1               5
</s400>
<s200>
<s210>8</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 8
Ser Ile Ser Ser Ser Gly Gly Trp Thr Leu Tyr Ala Asp Ser Val Lys
1               5                   10                  15
Gly
</s400>
<s200>
<s210>9</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 9
Gly Leu Lys Met Ala Thr Ile Phe Asp Tyr
1               5                   10
</s400>
<s200>
<s210>10</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 10
Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr Asn Val Val Ser
1               5                   10
</s400>
<s200>
<s210>11</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 11
Glu Val Ser Gln Arg Pro Ser
1               5
</s400>
<s200>
<s210>12</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 12
Cys Ser Tyr Ala Gly Ser Ser Ile Phe Val Ile
1               5                   10
</s400>
<s200>
<s210>13</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 13
Ala Tyr Asn Met Arg
1               5
</s400>
<s200>
<s210>14</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 14
Val Ile Tyr Pro Ser Gly Gly Ala Thr Arg Tyr Ala Asp Ser Val Lys
1               5                   10                  15
Gly
</s400>
<s200>
<s210>15</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 15
Gly Tyr Tyr Tyr Tyr Gly Met Asp Val
1               5
</s400>
<s200>
<s210>16</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 16
Ser Gly Ser Asp Ser Asn Ile Gly Arg Asn Tyr Ile Tyr
1               5                   10
</s400>
<s200>
<s210>17</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 17
Arg Asn Asn Gln Arg Pro Ser
1               5
</s400>
<s200>
<s210>18</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 18
Gly Thr Trp Asp Asp Ser Leu Ser Gly Pro Val
1               5                   10
</s400>
<s200>
<s210>19</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 19
Ala Tyr Gly Met Gly
1               5
</s400>
<s200>
<s210>20</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 20
Tyr Ile Ser Pro Ser Gly Gly His Thr Lys Tyr Ala Asp Ser Val Lys
1               5                   10                  15
Gly
</s400>
<s200>
<s210>21</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 21
Val Leu Glu Thr Gly Leu Leu Val Asp Ala Phe Asp Ile
1               5                   10
</s400>
<s200>
<s210>22</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 22
Ser Gly Asp Gln Leu Gly Ser Lys Phe Val Ser
1               5                   10
</s400>
<s200>
<s210>23</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 23
Tyr Lys Asp Lys Arg Arg Pro Ser
1               5
</s400>
<s200>
<s210>24</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 24
Gln Ala Trp Asp Ser Ser Thr Tyr Val
1               5
</s400>
<s200>
<s210>25</s210>
<s211>118</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 25
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1               5                   10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Trp Tyr
            20                  25                  30
Gly Met Gly Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Tyr Ile Ser Pro Ser Gly Gly Ile Thr Val Tyr Ala Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Leu Asn Tyr Tyr Tyr Gly Leu Asp Val Trp Gly Gln Gly Thr
            100                 105                 110
Thr Val Thr Val Ser Ser
        115
</s400>
<s200>
<s210>26</s210>
<s211>108</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 26
Gln Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val
1               5                   10                  15
Gly Asp Arg Ile Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Asp
            20                  25                  30
Ser Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Arg Leu Leu
        35                  40                  45
Ile Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser
    50                  55                  60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Phe Arg Ser Leu Gln
65                  70                  75                  80
Pro Glu Asp Ile Ala Thr Tyr Phe Cys Gln Gln Ser Ala Asn Ala Pro
                85                  90                  95
Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
            100                 105
</s400>
<s200>
<s210>27</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 27
Trp Tyr Gly Met Gly
1               5
</s400>
<s200>
<s210>28</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 28
Tyr Ile Ser Pro Ser Gly Gly Ile Thr Val Tyr Ala Asp Ser Val Lys
1               5                   10                  15
Gly
</s400>
<s200>
<s210>29</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 29
Leu Asn Tyr Tyr Tyr Gly Leu Asp Val
1               5
</s400>
<s200>
<s210>30</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 30
Gln Ala Ser Gln Asp Ile Gly Asp Ser Leu Asn
1               5                   10
</s400>
<s200>
<s210>31</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 31
Asp Ala Ser Asn Leu Glu Thr
1               5
</s400>
<s200>
<s210>32</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 32
Gln Gln Ser Ala Asn Ala Pro Phe Thr
1               5
</s400>
<s200>
<s210>33</s210>
<s211>119</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 33
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1               5                   10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr
            20                  25                  30
Gly Met Trp Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ser Tyr Ile Gly Ser Ser Gly Gly Pro Thr Tyr Tyr Val Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Gly Gly Arg Gly Thr Pro Tyr Tyr Phe Asp Ser Trp Gly Gln Gly
            100                 105                 110
Thr Leu Val Thr Val Ser Ser
        115
</s400>
<s200>
<s210>34</s210>
<s211>110</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 34
Gln Tyr Glu Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1               5                   10                  15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Ile Gly Arg Trp
            20                  25                  30
Asn Ile Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45
Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
    50                  55                  60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65                  70                  75                  80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
                85                  90                  95
Ser Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110
</s400>
<s200>
<s210>35</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 35
Arg Tyr Gly Met Trp
1               5
</s400>
<s200>
<s210>36</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 36
Tyr Ile Gly Ser Ser Gly Gly Pro Thr Tyr Tyr Val Asp Ser Val Lys
1               5                   10                  15
Gly
</s400>
<s200>
<s210>37</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 37
Gly Arg Gly Thr Pro Tyr Tyr Phe Asp Ser
1               5                   10
</s400>
<s200>
<s210>38</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 38
Thr Gly Thr Ser Ser Asp Ile Gly Arg Trp Asn Ile Val Ser
1               5                   10
</s400>
<s200>
<s210>39</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 39
Asp Val Ser Asn Arg Pro Ser
1               5
</s400>
<s200>
<s210>40</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 40
Ser Ser Tyr Thr Ser Ser Ser Thr Trp Val
1               5                   10
</s400>
<s200>
<s210>41</s210>
<s211>1095</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic polypeptide&#x201d;</s223>
</s220>
</s200>
<s400> 41
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1               5                   10                  15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
    50                  55                  60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65                  70                  75                  80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
            100                 105                 110
Leu Val Thr Val Ser Ser Ala Ser Thr Gly Gly Gly Gly Ser Gly Gly
        115                 120                 125
Gly Gly Ser Gly Gly Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala
    130                 135                 140
Ser Val Ser Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly
145                 150                 155                 160
Thr Ser Ser Asp Val Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln
                165                 170                 175
His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg
            180                 185                 190
Pro Ser Gly Val Ser Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr
        195                 200                 205
Ala Ser Leu Ile Ile Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr
    210                 215                 220
Tyr Cys Ser Ser Tyr Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly
225                 230                 235                 240
Gly Thr Lys Val Thr Val Leu Gly Ala Ala Ser Asp Ala His Lys Ser
                245                 250                 255
Glu Val Ala His Arg Phe Lys Asp Leu Gly Glu Glu Asn Phe Lys Ala
            260                 265                 270
Leu Val Leu Ile Ala Phe Ala Gln Tyr Leu Gln Gln Ser Pro Phe Glu
        275                 280                 285
Asp His Val Lys Leu Val Asn Glu Val Thr Glu Phe Ala Lys Thr Cys
    290                 295                 300
Val Ala Asp Glu Ser Ala Glu Asn Cys Asp Lys Ser Leu His Thr Leu
305                 310                 315                 320
Phe Gly Asp Lys Leu Cys Thr Val Ala Thr Leu Arg Glu Thr Tyr Gly
                325                 330                 335
Glu Met Ala Asp Cys Cys Ala Lys Gln Glu Pro Glu Arg Asn Glu Cys
            340                 345                 350
Phe Leu Gln His Lys Asp Asp Asn Pro Asn Leu Pro Arg Leu Val Arg
        355                 360                 365
Pro Glu Val Asp Val Met Cys Thr Ala Phe His Asp Asn Glu Glu Thr
    370                 375                 380
Phe Leu Lys Lys Tyr Leu Tyr Glu Ile Ala Arg Arg His Pro Tyr Phe
385                 390                 395                 400
Tyr Ala Pro Glu Leu Leu Phe Phe Ala Lys Arg Tyr Lys Ala Ala Phe
                405                 410                 415
Thr Glu Cys Cys Gln Ala Ala Asp Lys Ala Ala Cys Leu Leu Pro Lys
            420                 425                 430
Leu Asp Glu Leu Arg Asp Glu Gly Lys Ala Ser Ser Ala Lys Gln Arg
        435                 440                 445
Leu Lys Cys Ala Ser Leu Gln Lys Phe Gly Glu Arg Ala Phe Lys Ala
    450                 455                 460
Trp Ala Val Ala Arg Leu Ser Gln Arg Phe Pro Lys Ala Glu Phe Ala
465                 470                 475                 480
Glu Val Ser Lys Leu Val Thr Asp Leu Thr Lys Val His Thr Glu Cys
                485                 490                 495
Cys His Gly Asp Leu Leu Glu Cys Ala Asp Asp Arg Ala Asp Leu Ala
            500                 505                 510
Lys Tyr Ile Cys Glu Asn Gln Asp Ser Ile Ser Ser Lys Leu Lys Glu
        515                 520                 525
Cys Cys Glu Lys Pro Leu Leu Glu Lys Ser His Cys Ile Ala Glu Val
    530                 535                 540
Glu Asn Asp Glu Met Pro Ala Asp Leu Pro Ser Leu Ala Ala Asp Phe
545                 550                 555                 560
Val Glu Ser Lys Asp Val Cys Lys Asn Tyr Ala Glu Ala Lys Asp Val
                565                 570                 575
Phe Leu Gly Met Phe Leu Tyr Glu Tyr Ala Arg Arg His Pro Asp Tyr
            580                 585                 590
Ser Val Val Leu Leu Leu Arg Leu Ala Lys Thr Tyr Glu Thr Thr Leu
        595                 600                 605
Glu Lys Cys Cys Ala Ala Ala Asp Pro His Glu Cys Tyr Ala Lys Val
    610                 615                 620
Phe Asp Glu Phe Lys Pro Leu Val Glu Glu Pro Gln Asn Leu Ile Lys
625                 630                 635                 640
Gln Asn Cys Glu Leu Phe Glu Gln Leu Gly Glu Tyr Lys Phe Gln Asn
                645                 650                 655
Ala Leu Leu Val Arg Tyr Thr Lys Lys Val Pro Gln Val Ser Thr Pro
            660                 665                 670
Thr Leu Val Glu Val Ser Arg Asn Leu Gly Lys Val Gly Ser Lys Cys
        675                 680                 685
Cys Lys His Pro Glu Ala Lys Arg Met Pro Cys Ala Glu Asp Tyr Leu
    690                 695                 700
Ser Val Val Leu Asn Gln Leu Cys Val Leu His Glu Lys Thr Pro Val
705                 710                 715                 720
Ser Asp Arg Val Thr Lys Cys Cys Thr Glu Ser Leu Val Asn Arg Arg
                725                 730                 735
Pro Cys Phe Ser Ala Leu Glu Val Asp Glu Thr Tyr Val Pro Lys Glu
            740                 745                 750
Phe Gln Ala Glu Thr Phe Thr Phe His Ala Asp Ile Cys Thr Leu Ser
        755                 760                 765
Glu Lys Glu Arg Gln Ile Lys Lys Gln Thr Ala Leu Val Glu Leu Val
    770                 775                 780
Lys His Lys Pro Lys Ala Thr Lys Glu Gln Leu Lys Ala Val Met Asp
785                 790                 795                 800
Asp Phe Ala Ala Phe Val Glu Lys Cys Cys Lys Ala Asp Asp Lys Glu
                805                 810                 815
Thr Cys Phe Ala Glu Glu Gly Lys Lys Leu Val Ala Ala Ser Gln Ala
            820                 825                 830
Ala Leu Gly Leu Ala Ala Ala Leu Gln Val Gln Leu Val Gln Ser Gly
        835                 840                 845
Ala Glu Val Lys Lys Pro Gly Glu Ser Leu Lys Ile Ser Cys Lys Gly
    850                 855                 860
Ser Gly Tyr Ser Phe Thr Ser Tyr Trp Ile Ala Trp Val Arg Gln Met
865                 870                 875                 880
Pro Gly Lys Gly Leu Glu Tyr Met Gly Leu Ile Tyr Pro Gly Asp Ser
                885                 890                 895
Asp Thr Lys Tyr Ser Pro Ser Phe Gln Gly Gln Val Thr Ile Ser Val
            900                 905                 910
Asp Lys Ser Val Ser Thr Ala Tyr Leu Gln Trp Ser Ser Leu Lys Pro
        915                 920                 925
Ser Asp Ser Ala Val Tyr Phe Cys Ala Arg His Asp Val Gly Tyr Cys
    930                 935                 940
Thr Asp Arg Thr Cys Ala Lys Trp Pro Glu Trp Leu Gly Val Trp Gly
945                 950                 955                 960
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Ser Gly
                965                 970                 975
Gly Gly Ser Gly Gly Gly Gly Ser Gln Ser Val Leu Thr Gln Pro Pro
            980                 985                 990
Ser Val Ser Ala Ala Pro Gly Gln  Lys Val Thr Ile Ser  Cys Ser Gly
        995                 1000                 1005
Ser Ser  Ser Asn Ile Gly Asn  Asn Tyr Val Ser Trp  Tyr Gln Gln
    1010                 1015                 1020
Leu Pro  Gly Thr Ala Pro Lys  Leu Leu Ile Tyr Asp  His Thr Asn
    1025                 1030                 1035
Arg Pro  Ala Gly Val Pro Asp  Arg Phe Ser Gly Ser  Lys Ser Gly
    1040                 1045                 1050
Thr Ser  Ala Ser Leu Ala Ile  Ser Gly Phe Arg Ser  Glu Asp Glu
    1055                 1060                 1065
Ala Asp  Tyr Tyr Cys Ala Ser  Trp Asp Tyr Thr Leu  Ser Gly Trp
    1070                 1075                 1080
Val Phe  Gly Gly Gly Thr Lys  Leu Thr Val Leu Gly
    1085                 1090                 1095
</s400>
<s200>
<s210>42</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 42
Ser Tyr Trp Met Ser
1               5
</s400>
<s200>
<s210>43</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 43
Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val Lys
1               5                   10                  15
Gly
</s400>
<s200>
<s210>44</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 44
Asp Arg Gly Val Gly Tyr Phe Asp Leu
1               5
</s400>
<s200>
<s210>45</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 45
Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn Phe Val Ser
1               5                   10
</s400>
<s200>
<s210>46</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 46
Asp Val Ser Asp Arg Pro Ser
1               5
</s400>
<s200>
<s210>47</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 47
Ser Ser Tyr Gly Ser Ser Ser Thr His Val Ile
1               5                   10
</s400>
<s200>
<s210>48</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 48
Ser Tyr Trp Ile Ala
1               5
</s400>
<s200>
<s210>49</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 49
Leu Ile Tyr Pro Gly Asp Ser Asp Thr Lys Tyr Ser Pro Ser Phe Gln
1               5                   10                  15
Gly
</s400>
<s200>
<s210>50</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 50
His Asp Val Gly Tyr Cys Thr Asp Arg Thr Cys Ala Lys Trp Pro Glu
1               5                   10                  15
Trp Leu Gly Val
            20
</s400>
<s200>
<s210>51</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 51
Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn Tyr Val Ser
1               5                   10
</s400>
<s200>
<s210>52</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 52
Asp His Thr Asn Arg Pro Ala
1               5
</s400>
<s200>
<s210>53</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s221>
source
</s221>
<s223>/note=&#x201c;Description of Artificial Sequence
      Synthetic peptide&#x201d;</s223>
</s220>
</s200>
<s400> 53
Ala Ser Trp Asp Tyr Thr Leu Ser Gly Trp Val
1               5                   10
</s400>
</sequence-list-new-rules>
</sequence-cwu>
